Furman RR - Search Results

1

Cutaneous CD4+ CD56+ hematologic malignancies.

Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN. Magro CM, et al. Among authors: furman rr. J Am Acad Dermatol. 2010 Aug;63(2):292-308. doi: 10.1016/j.jaad.2009.08.044. Epub 2010 Jun 11. J Am Acad Dermatol. 2010. PMID: 20541283

2

Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery.

Gordon JK, Magro C, Lu T, Schneider R, Chiu A, Furman RR, Solomon G, Bass A, Erkan D. Gordon JK, et al. Among authors: furman rr. HSS J. 2009 Sep;5(2):169-77. doi: 10.1007/s11420-009-9123-x. Epub 2009 Jul 16. HSS J. 2009. PMID: 19609622 Free PMC article. No abstract available.

3

Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.

Fraser CR, Wang W, Gomez M, Zhang T, Mathew S, Furman RR, Knowles DM, Orazi A, Tam W. Fraser CR, et al. Among authors: furman rr. Am J Clin Pathol. 2009 Dec;132(6):928-39. doi: 10.1309/AJCPWQ0I0DGXBMHO. Am J Clin Pathol. 2009. PMID: 19926586

4

Roboz GJ, Bennett JM, Coleman M, Ritchie EK, Furman RR, Rossi A, Jhaveri K, Feldman EJ, Leonard JP. Roboz GJ, et al. Among authors: furman rr. Leuk Res. 2007 Aug;31(8):1141-4. doi: 10.1016/j.leukres.2006.11.011. Epub 2007 May 1. Leuk Res. 2007. PMID: 17475326

5

Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignancies.

Furman RR, Hoelzer D. Furman RR, et al. Semin Oncol. 2007 Dec;34(6 Suppl 5):S29-34. doi: 10.1053/j.seminoncol.2007.11.004. Semin Oncol. 2007. PMID: 18086344 Review.

6

Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.

Song Z, Lu P, Furman RR, Leonard JP, Martin P, Tyrell L, Lee FY, Knowles DM, Coleman M, Wang YL. Song Z, et al. Among authors: furman rr. Clin Cancer Res. 2010 Jan 15;16(2):587-99. doi: 10.1158/1078-0432.CCR-09-1519. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068106

7

Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.

Furman RR, Martin P, Ruan J, Cheung YK, Vose JM, LaCasce AS, Elstrom R, Coleman M, Leonard JP. Furman RR, et al. Cancer. 2010 Dec 1;116(23):5432-9. doi: 10.1002/cncr.25509. Epub 2010 Jul 27. Cancer. 2010. PMID: 20665890 Free article. Clinical Trial.

8

Prognostic markers and stratification of chronic lymphocytic leukemia.

Furman RR. Furman RR. Hematology Am Soc Hematol Educ Program. 2010;2010:77-81. doi: 10.1182/asheducation-2010.1.77. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239774

9

Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.

Vaisitti T, Braggio E, Allan JN, Arruga F, Serra S, Zamò A, Tam W, Chadburn A, Furman RR, Deaglio S. Vaisitti T, et al. Among authors: furman rr. Cancer Res. 2018 Jul 1;78(13):3413-3420. doi: 10.1158/0008-5472.CAN-17-4004. Epub 2018 May 7. Cancer Res. 2018. PMID: 29735551

10

Highlights in B-cell malignancies from the 61st American Society of Hematology Annual Meeting: commentary.

Furman RR. Furman RR. Clin Adv Hematol Oncol. 2020 Feb;18 Suppl 8(2):24-26. Clin Adv Hematol Oncol. 2020. PMID: 33843883 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters